一种基于PCR的下一代片序列测序方法,用于家族高胆固醇血遗传查的快速和可扩展的多重复合
Mohamed Imran1,2, V R Arvinden1,2, Pabithadevi Balaiah Mehanathan3
1CSIR-Institute of Genomics and Integrative Biology, New Delhi, India.
The journal of applied laboratory medicine
|August 14, 2024
概括
一种新的多重片测序方法使得家族高胆固醇血症 (FH) 和相关的药物基因组变异的有效基因检测成为可能,改善了查和他类药物的剂量. 这种具有成本效益的方法可以提高FH的诊断和管理.
科学领域:
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
- 心血管疾病 心血管疾病
背景情况:
- 家族性高胆固醇血症 (FH) 是一种被诊断不足的遗传疾病,导致高的LDL胆固醇.
- 对LDLR,APOB和PCSK9基因的基因测试可以识别变异,但目前的测序方法存在局限性.
- 药物基因组变异会影响FH患者对他类药物的反应,需要量身定制的治疗.
研究的目的:
- 为FH遗传测试开发一种成本效益高且可扩展的基于多重原料的amplicon测序方法.
- 同时分析FH致病基因 (LDLR,APOB,PCSK9) 和关键的药物基因组变异.
- 提高FH遗传诊断的效率和可负担性.
主要方法:
- 针对LDLR,APOB,PCSK9外因子和药物基因组变异 (SLCO1B1,ABCG2) 的设计多重原料.
- 采用基于珠子的标记来准备图书馆和NovaSeq 6000进行测序.
- 通过已知样本和12个疑似FH的试剂进行了分析和临床验证.
主要成果:
- 实现了高覆盖率 (>100×) 没有安普利康掉落.
- 在LDLR中成功检测出已知的变异,并确定了新的致病变异.
- 根据药物基因组发现,确定了3名可能需要调整他类药物剂量的患者.
- 证明了图书馆准备时间 (~3小时) 和成本 (<50美元) 的减少.
结论:
- 开发的方法有效地测序了关键的FH基因和药物基因组变异.
- 这种方法提高了FH遗传检测的效率和可负担性.
- 结果将指导适当的FH查和个性化他类药物剂量策略.
更多相关视频
05:58Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format
Published on: August 20, 2018
10.8K
08:22A Robust Polymerase Chain Reaction-based Assay for Quantifying Cytosine-guanine-guanine Trinucleotide Repeats in Fragile X Mental Retardation-1 Gene
Published on: September 16, 2019
7.8K
相关概念视频
03:00Next-generation Sequencing
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...